# PegIntron Injection Surveillance Plan (Study P04123)

> **NCT00723931** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1267 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **BIOLOGICAL:** Peginterferon alfa-2b (SCH 54031)

## Key facts

- **NCT ID:** NCT00723931
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 1267 (ACTUAL)
- **Last updated:** 2015-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00723931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00723931, "PegIntron Injection Surveillance Plan (Study P04123)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00723931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*